Data as of November 1, 2024
This table displays the countermeasure and injury for each CICP claim filed between Fiscal Years 2010 and 2025 that was eligible for compensation, but did not have eligible reported losses or expenses.
Please note that the number column within the tables are not assigned numbers for a particular claim, but reflect the number of listed items in a given table. Further details concerning the table contents are provided below.
| Number | Covered Countermeasure | Covered Injury |
|---|---|---|
| 1 | H1N1 Vaccine | Guillain-Barré Syndrome (GBS) |
| 2 | H1N1 Vaccine | GBS |
| 3 | Smallpox Vaccine | Myocarditis |
| 4 | H1N1 Vaccine | Anaphylaxis |
| 5 | H1N1 Vaccine | GBS |
| 6 | Smallpox Vaccine | Serum sickness |
| 7 | H1N1 Vaccine | Herpes Zoster Outbreak |
| 8 | H1N1 Vaccine | GBS |
| 9 | H1N1 Vaccine | GBS |
| 10 | H1N1 Vaccine | GBS |
| 11 | COVID-19 Vaccine | Myocarditis |
Fecha de la última revisión: